What's Happening?
Molecular Instruments has announced the release of HCR™ Gold IF on the BOND RX research staining instrument, developed in collaboration with Leica Biosystems. This new offering aims to improve automated multiplex immunofluorescence workflows, allowing
researchers to transition from tissue samples to biological insights more efficiently. The HCR™ Gold IF enables flexible multiplex protein detection using off-the-shelf primary antibodies, supporting the use of multiple primary antibodies from the same host species and isotype without disrupting established workflows. This development is part of Molecular Instruments' broader vision to enhance imaging approaches and provide richer biological insights from valuable samples.
Why It's Important?
The introduction of HCR™ Gold IF represents a significant advancement in spatial biology and translational research applications. By enabling more flexible and reproducible multiplex protein detection, this technology supports research teams in achieving higher throughput and greater flexibility. This is particularly important for academic research, drug development, and clinical pathology, where precise and efficient analysis of tissue samples is crucial. The collaboration with Leica Biosystems, a leader in anatomic and digital pathology solutions, underscores the potential impact of this technology in advancing cancer diagnostics and improving lives.
